Jason Oh, MD
Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1629413877
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 43.1% of the total. Reporting peaked in 2020 at $2,296 and has fallen 87.1% since, to $296 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.
Across 46 payments — averaging $173.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Zimmer Biomet$2K
- Sanara Medtech Inc.$1K
- Davol Inc.$804
- DJO, LLC$146
- KCI USA, Inc.$119
- plus $179 from 2 others
Across 29 payments — averaging $2154.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$62K
What the payments were for
- Consulting fees$79210%
- Travel & lodging$2,45331%
- Food & beverage$3,41143%
- Education$1,34617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $3,446 |
| Zimmer Biomet | 13 | $2,150 |
| Sanara Medtech Inc. | 7 | $1,158 |
| Davol Inc. | 7 | $804 |
| DJO, LLC | 1 | $146 |
| KCI USA, Inc. | 1 | $119 |
| Pacira Therapeutics, Inc. | 1 | $105 |
| Highridge Medical LLC | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,003 in reported general payments places this provider in the 40th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 155 | $1,954 |
| Diclofenac Sodium | 65 | $1,221 |
| Meloxicam | 219 | $474 |
| Pregabalin | 13 | $362 |
| Methylprednisolone | 26 | $173 |
| Gabapentin | 46 | $141 |
| Cefadroxil | 14 | $133 |
| Tramadol Hcl | 16 | $55 |
| Pantoprazole Sodium | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New York
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.